These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 26657827)

  • 1. Proportion of osteoporotic women remaining at risk for fracture despite adherence to oral bisphosphonates.
    Imel EA; Eckert G; Modi A; Li Z; Martin J; de Papp A; Allen K; Johnston CC; Hui SL; Liu Z
    Bone; 2016 Feb; 83():267-275. PubMed ID: 26657827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoporotic fracture rate among women with at least 1 year of adherence to osteoporosis treatment.
    Modi A; Tang J; Sen S; Díez-Pérez A
    Curr Med Res Opin; 2015 Apr; 31(4):767-77. PubMed ID: 25708648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subjects with osteoporosis to remain at high risk for fracture despite benefit of prior bisphosphonate treatment-a Danish case-control study.
    Hansen L; Petersen KD; Eriksen SA; Gerstoft F; Vestergaard P
    Osteoporos Int; 2017 Jan; 28(1):321-328. PubMed ID: 27475930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of bisphosphonate compliance on the risk of osteoporotic fracture in France.
    Belhassen M; Cortet B; Confavreux CB; Lamezec L; Ginoux M; Van Ganse E
    Arch Osteoporos; 2018 Oct; 13(1):113. PubMed ID: 30341636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proportion and Characteristics of Patients in Sweden Remaining at High Risk of Fracture Despite Prior Treatment.
    Mellström D; Yang X; Li Z; Fan CP; Waern E; Modi A; Sajjan S; Salomonsson S
    Clin Ther; 2016 Jul; 38(7):1686-1695.e3. PubMed ID: 27288211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Association Between Long-Term Bisphosphonate Use and the Risk of Fracture Among Women Aged 50 or Older with Osteoporosis.
    Wang CC; Lu HT; Dusetzina SB; Wu CH
    J Womens Health (Larchmt); 2016 Jul; 25(7):738-46. PubMed ID: 27096405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Denosumab: a cost-effective alternative for older men with osteoporosis from a Swedish payer perspective.
    Parthan A; Kruse M; Agodoa I; Silverman S; Orwoll E
    Bone; 2014 Feb; 59():105-13. PubMed ID: 24231131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment for older men with fractures.
    Shepherd AJ; Cass AR; Ray LA; Tan A; Wilkinson GS
    Osteoporos Int; 2012 Mar; 23(3):1041-51. PubMed ID: 21811867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of change in bone mineral density and fracture risk during bisphosphonate holiday.
    Xu LH; Adams-Huet B; Poindexter JR; Maalouf NM
    Osteoporos Int; 2016 May; 27(5):1701-8. PubMed ID: 26642963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term impact of adherence to oral bisphosphonates on osteoporotic fracture incidence.
    Sampalis JS; Adachi JD; Rampakakis E; Vaillancourt J; Karellis A; Kindundu C
    J Bone Miner Res; 2012 Jan; 27(1):202-10. PubMed ID: 21976304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoporosis prevalence and characteristics of treated and untreated nursing home residents with osteoporosis.
    Zarowitz BJ; Cheng LI; Allen C; O'Shea T; Stolshek B
    J Am Med Dir Assoc; 2015 Apr; 16(4):341-8. PubMed ID: 25726417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disparities in osteoporosis treatments.
    Liu Z; Weaver J; de Papp A; Li Z; Martin J; Allen K; Hui S; Imel EA
    Osteoporos Int; 2016 Feb; 27(2):509-19. PubMed ID: 26216226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of bisphosphonate therapies for women with postmenopausal osteoporosis: implications of improved persistence with less frequently administered oral bisphosphonates.
    Earnshaw SR; Graham CN; Ettinger B; Amonkar MM; Lynch NO; Middelhoven H
    Curr Med Res Opin; 2007 Oct; 23(10):2517-29. PubMed ID: 17825128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost and Consequences of Nonadherence With Oral Bisphosphonate Therapy: Findings From a Real-World Data Analysis.
    Sharman Moser S; Yu J; Goldshtein I; Ish-Shalom S; Rouach V; Shalev V; Modi A; Chodick G
    Ann Pharmacother; 2016 Apr; 50(4):262-9. PubMed ID: 26783359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous zoledronic acid and oral alendronate in patients with a low trauma fracture: experience from an osteoporosis clinic.
    Craig SJ; Youssef PP; Vaile JH; Sullivan L; Bleasel JF
    Intern Med J; 2011 Feb; 41(2):186-90. PubMed ID: 20214696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for fracture among current, persistent users of bisphosphonates.
    LeBlanc ES; Rosales AG; Balasubramanian A; O'Malley CD; Egbuna O; Friess D; Perrin NA
    Osteoporos Int; 2015 Feb; 26(2):713-25. PubMed ID: 25354654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of refracture associated with compliance and persistence with bisphosphonate therapy in Taiwan.
    Soong YK; Tsai KS; Huang HY; Yang RS; Chen JF; Wu PC; Huang KE
    Osteoporos Int; 2013 Feb; 24(2):511-21. PubMed ID: 22588182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fracture during oral bisphosphonate therapy is associated with deteriorated bone material strength index.
    Nogués X; Prieto-Alhambra D; Güerri-Fernández R; Garcia-Giralt N; Rodriguez-Morera J; Cos L; Mellibovsky L; Pérez AD
    Bone; 2017 Oct; 103():64-69. PubMed ID: 28655603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence With Bisphosphonates and Long-Term Risk of Hip Fractures: A Nested Case-Control Study Using Real-World Data.
    Shalev V; Sharman Moser S; Goldshtein I; Yu J; Weil C; Ish-Shalom S; Rouach V; Chodick G
    Ann Pharmacother; 2017 Sep; 51(9):757-767. PubMed ID: 28535690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of a decline in bone mineral density while receiving oral bisphosphonate treatment.
    Sebba AI
    Clin Ther; 2008 Mar; 30(3):443-52. PubMed ID: 18405784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.